USSTOCK.TODAY
Regular Market
Log in Sign up

Comparison of Moderna and Vertex Pharmaceuticals' Earnings and Business Strategies

The Motley Fool +1 ·

VRTX Vertex Pharmaceuticals Inc
$507.00 -0.60%
View chart & analysis →
  1. 1Moderna's revenue for fiscal year 2025 recorded $1.9 billion, a decrease of approximately 39.2% in Moderna's revenue growth rate compared to the previous year.
  2. 2Vertex Pharmaceuticals' revenue for fiscal year 2025 approached $12.1 billion, growing approximately 9.6% compared to the previous year.
  3. 3Vertex Pharmaceuticals management raised the annual outlook in the second quarter of 2026.

So what's the key point?

Moderna's revenue decreased by 39.2% compared to last year. Vertex Pharmaceuticals saw an increase in revenue, and management set a higher outlook for next year.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Goldman Sachs Updates September Conviction List, Swaps US and European Names Investing.com +1 · Sep 2Sionna Therapeutics shares plunge 92% as SION-719 misses Phase 2a endpoint InvestorsHub +3 · Aug 10Ultra Clean Holdings (UCTT) Q2 net income $8.7 million Associated Press +1 · Aug 4
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news